BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Campanelli F, Natale G, Marino G, Ghiglieri V, Calabresi P. Striatal glutamatergic hyperactivity in Parkinson's disease. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Suthard RL, Jellinger AL, Surets M, Shpokayte M, Pyo AY, Buzharsky MD, Senne RA, Dorst K, Leblanc H, Ramirez S. Chronic Gq activation of ventral hippocampal neurons and astrocytes differentially affects memory and behavior. Neurobiol Aging 2023;125:9-31. [PMID: 36801699 DOI: 10.1016/j.neurobiolaging.2023.01.007] [Reference Citation Analysis]
2 Kang MS, Hamadjida A, Bédard D, Nuara SG, Gourdon JC, Frey S, Aliaga A, Ross K, Hopewell R, Bdair H, Mathieu A, Tardif CL, Soucy JP, Massarweh G, Rosa-Neto P, Huot P. Distribution of [(11)C]-JNJ-42491293 in the marmoset brain: a positron emission tomography study. Naunyn Schmiedebergs Arch Pharmacol 2023. [PMID: 36928556 DOI: 10.1007/s00210-023-02458-w] [Reference Citation Analysis]
3 Bourque M, Morissette M, Conquet F, Charvin D, Di Paolo T. Foliglurax, a positive allosteric modulator of the metabotrophic glutamate receptor 4, protects dopaminergic neurons in MPTP-lesioned male mice. Brain Research 2023. [DOI: 10.1016/j.brainres.2023.148349] [Reference Citation Analysis]
4 Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A, Kumar D, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev 2023;85:101838. [PMID: 36610558 DOI: 10.1016/j.arr.2022.101838] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Amato S, Averna M, Guidolin D, Ceccoli C, Gatta E, Candiani S, Pedrazzi M, Capraro M, Maura G, Agnati LF, Cervetto C, Marcoli M. Heteromerization of Dopamine D2 and Oxytocin Receptor in Adult Striatal Astrocytes. Int J Mol Sci 2023;24. [PMID: 36902106 DOI: 10.3390/ijms24054677] [Reference Citation Analysis]
6 Zhang X, Wang K, Ren XL, Zhang MD, Wu KN, Wu H, Chu ZW, Liu SS, Jiang XX, Zhu JH, Wu HM. Zinc Deficiency Exacerbates Behavioral Impediments and Dopaminergic Neuron Degeneration in a Mouse Model of Parkinson Disease. J Nutr 2023;153:167-75. [PMID: 36913450 DOI: 10.1016/j.tjnut.2022.11.006] [Reference Citation Analysis]
7 Suthard RL, Jellinger AL, Shpokayte M, Surets M, Pyo AY, Buzharsky MD, Senne RA, Leblanc H, Ramirez S. Chronic Gq activation of ventral hippocampal neurons and astrocytes differentially affects memory and behavior.. [DOI: 10.1101/2022.09.15.508157] [Reference Citation Analysis]
8 Calabrese V, Picconi B, Heck N, Campanelli F, Natale G, Marino G, Sciaccaluga M, Ghiglieri V, Tozzi A, Anceaume E, Cuoc E, Caboche J, Conquet F, Calabresi P, Charvin D. A positive allosteric modulator of mGlu4 receptors restores striatal plasticity in an animal model of l-Dopa-induced dyskinesia. Neuropharmacology 2022. [DOI: 10.1016/j.neuropharm.2022.109205] [Reference Citation Analysis]
9 Frouni I, Huot P. Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinic. Neurodegenerative Disease Management. [DOI: 10.2217/nmt-2021-0055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]